Medication info
Telmisartan Plus Tablet 80/12.5 mg

Telmisartan Plus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex round tablets
Packaging
30 tablets (10 tablets/PTP x 3), 100 tablets/bottle
Approval status
Active

MFDS item code 201300145 · Approved 2013.01.08 · Insurance code 645403920

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended to adjust the dose of each component individually for the patient. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this drug with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this drug per day. Do not administer this drug to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be used with caution in patients with impaired hepatic function. Older adults No dose adjustment is necessary.
Child dose
The safety and efficacy of this drug have not been established in children under 18 years of age.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan monotherapy

  • Essential hypertension
View approved original text

This medication is used when blood pressure control is difficult with monotherapy of telmisartan in patients with essential hypertension. Adding this medication helps effectively lower blood pressure and manage health.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended to adjust the dose of each component individually for the patient. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this drug with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this drug per day. Do not administer this drug to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be used with caution in patients with impaired hepatic function. Older adults No dose adjustment is necessary.

Child dose

The safety and efficacy of this drug have not been established in children under 18 years of age.

Precautions

This medication can pose serious risks to the fetus or newborn, thus it should not be used during pregnancy, especially in the second and third trimesters. Treatment should be discontinued immediately if pregnancy is confirmed, and other safe alternatives should be considered. Patients allergic to any of the ingredients or excipients contained in this medication should not take it. Moreover, patients allergic to sulfonamide drugs, pregnant or nursing individuals, patients with cholestasis or biliary obstruction, and those with severe liver or kidney dysfunction should also avoid this medication. Elderly patients, those with high potassium levels, or liver impairment, and patients with heart valve disease or cardiovascular disease should use this medication with caution. Hydrochlorothiazide may cause sensitivity to sunlight, increasing the risk of skin cancer; therefore, ultraviolet exposure should be limited and skin conditions monitored periodically during treatment. This medication lowers blood pressure, which may cause dizziness, fainting, drowsiness, and caution is required when driving or operating machinery. This medication may interact with other drugs; especially when combined with medications affecting potassium levels, lithium, non-steroidal anti-inflammatory drugs, or other antihypertensive drugs, consultation with health care professionals and regular blood tests are required. In case of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur; immediate contact with a medical institution for appropriate treatment is necessary. It is advisable not to use this medication in children under 18 years of age, as safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 116 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory discomfort
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disorder
  • vascular edema
  • erythema
  • pruritus
  • rash
  • sweating
  • urticaria
  • back pain
  • muscle cramp
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • myasthenia
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • increased liver enzymes
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • myasthenia
  • fever
  • nausea
  • abdominal pain
  • gastrointestinal hemorrhage
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • anxiety
  • proteinuria
  • rash
  • itching
  • myalgia
  • floating sensation
  • lip and hand tremor
  • hypersensitivity
  • gum disease
  • dry lips
  • visual impairment
  • hypotension
  • tachycardia
  • nausea
  • somnolence
  • muscle spasm

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain the efficacy of the medication and prevent degradation.

Appearance and packaging

Appearance

White or almost white, biconvex round tablets

Package unit

30 tablets (10 tablets/PTP x 3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.